The Multiple Myeloma Channel is supported with funding from BMS (Gold) and Legend Biotech (Bronze).
VJHemOnc is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
EBMT 2019 | Treatment considerations at first relapse after transplantation
Maria Victoria-Mateos
• 24 Mar 2019
Here, Maria-Victoria Mateos, MD, PhD, from University Hospital of Salamanca, Salamanca, Spain, speaks about factors to consider in treatment at first relapse post-transplantation. Dr Mateos was speaking at the European Society for Blood and Marrow Transplantation (EBMT) 2019 Annual Meeting, held in Frankfurt, Germany.
